Increased insulin-like growth factor and platelet-derived growth factor system in the pyloric muscle in infantile hypertrophic pyloric stenosis

Journal of Pediatric Surgery

Volumn 33, Issue 2, 1998, Pages 378-381

  Ohshiro, Kiyohiko ^a   Puri, Prem ^a  

^a OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

Growth factors; Immunohistochemistry; Infantile hypertrophic pyloric stenosis; Insulin like growth factor I; Platelet derived growth factor

Indexed keywords

PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN;

AUTOPSY; CELL PROLIFERATION; CONFERENCE PAPER; EXTRACELLULAR MATRIX; GENETIC PREDISPOSITION; HUMAN; HUMAN TISSUE; HYPERTROPHIC PYLORUS STENOSIS; IMMUNOHISTOCHEMISTRY; MUSCLE BIOPSY; PRIORITY JOURNAL; PYLORUS; RECEPTOR UPREGULATION; SMOOTH MUSCLE FIBER;

EID: 0031936209     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3468(98)90467-5     Document Type: Conference Paper

References (26)

1. Puri P, Lakschmanadass G: Hypertrophic pyloric Stenosis, in Puri P (ed): Newborn Surgery. Oxford, England, Butterworth-Heinemann, 1996, pp 266-271, (chapt 35)
2. Dodge JA: Production of duodenal ulcers and hypertrophic pyloric stenosis by administration of pentagastrin to pregnant and newborn dogs. Nature 225:284-285, 1970
3. Spitz L, Zail SS: Serum gastrin levels in congenital hypertrophic pyloric stenosis. J Pediatr Surg 11:33-35, 1976
4. Spitz L, Kaufmann JCE: The neuropathological changes in congenital pyloric stenosis. S Afr J Surg 13:239-242, 1975
5. Wattchow DA, Cass DT, Furness JB, et al: Abnormalities of peptide-containing nerve fibers in infantile hypertrophic pyloric stenosis. Gastroenterology 92:443-448, 1987
6. Vanderwinden JM, Milieux P, Schiffman SN: Nitric oxide synthase activity in infantile hypertrophic pyloric stenosis. N Engl J Med 327:511-515, 1992
7. Kobayashi H, O'Briain DS, Puri P: Immunochemical characterization of neural cell adhesion molecule, nitric oxide synthase, and neurofilament protein expression in pyloric muscle of patients with pyloric stenosis. J Pediatr Gastroenterol Nutr 20:319-325, 1995
8. Kusafuka T, Puri P: Altered mRNA expression of the neuronal nitric oxide synthase gene in infantile hypertrophic pyloric stenosis. Pediatr Surg Int (in press)
9. Kobayashi H, O'Briain DS, Puri P: Selective reduction in intramuscular nerve supporting cells in infantile hypertrophic pyloric stenosis. J Pediatr Surg 29:651-654, 1994
10. Cass DT, Zhang AL: Extracellular matrix changes in congenital hypertophic pyloric stenosis. Pediatr Surg Int 6:190-194, 1991
11. Weinstein R, Stemmerma MB, Maciag T: Hormonal requirements for growth of arterial smooth muscle cells in vitro: An endocrine approach to atherosclerosis. Science 212:818, 1981
12. Raines E, Ross R: Mechanisms of plaque formation: Cellular changes and possible role of growth-regulatory molecules. Atheroscler Rev 23:143-152, 1991
13. Clemmons DR, Van Wyk JJ: Evidence for a functional role of endogenously produced somatomedine-like peptides in the regulation of DNA synthesis in cultured human fibroblast and porcine smooth muscle cells. J Clin Invest 75:1914-1918, 1985
14. Libby P, Warner SJC, Salomon RN, et al: Production of platelet-derived growth factor-like mitogen by smooth-muscle cells from human atheroma. N Engl J Med 318:1493-1496, 1988
15. Cercek B, Fishbein MC, Forrester JS, et al: Induction of insulin-like growth factor I messenger RNA in rat aorta after balloon denudation. Circ Res 66:1755-1760, 1990
16. Ullrich A, Gray A, Tam AW, et al: Insulin-like growth factor 1 receptor primary structure: Comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 5:2503-2512, 1986
17. Pfefile B, Boeder H, Ditschuneit H: Interaction of receptors of insulin-like growth factor I, platelet-derived growth factor, and fibroblast growth factor in rat aortic cells. Endocrinology 120:2251-2258, 1987
18. Froesch ER, Schmid C, Schwander J, et al: Actions of insulin-like growth factors. Ann Rev Physiol 47:443-453, 1985
19. Laburth M, Rouyer-Fessard C, Gammeltoft S: Receptors for insulin-like growth factors I and II in rat gastrointestinal epithelium. Am J Physiol 254:G457-G462, 1988
20. Langer JC, Berezin I, Daniel EE: Hypertrophic pyloric stenosis: Ultrastructural abnormalities of enteric nerves and the interstitial cells of Cajal. J Pediatr Surg 30:1535-1543, 1995
21. Devol DL, Rotwein P, Sadow JL: Activation of insulin-like growth factor gene expression during work-induced skeletal muscle growth. Am J Physiol 259:E89-E95, 1990
22. Wahlander H, Isgaard J, Jennische E, et al: Left ventricular insulin-like growth factor I increases in early renal hypertension. Hypertension Dallas 19:25-32, 1992
23. Chen Y, Bornfeldt KE, Arner A, et al: Increase in insulin-like growth factor I in hypertrophying smooth muscle. Am J Physiol 266:E224-E229, 1994
24. Bornfeldt KE, Arnqvist HJ: Effect of insulin-like growth factor-1 on metabolism in bovine mesenteric arteries. Acta Physiol Scand 131:563-568, 1987
25. Ito H, Hiroe Y, Hirata Y, et al: Insulin-like growth factor I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocyte. Circulation 87:1715-1721, 1993.
26. Giannella-Neto D, Kamyar A, Sharifi B, et al: Platelet-derived growth factor isoforms decrease insulin-like growth factor I gene expression in rat vascular smooth muscle cells and selectively stimulate the biosynthesis of insulin-like growth factor binding protein 4. Circ Res 71:646-656, 1992